Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

CDT Equity Inc.

  • NAPLES, Florida
  • Public · NASDAQ: CDT
  • 4 employees
$3.6MMarket cap
-$39.2MNet income
4Employees
CDTNASDAQ
2023IPO

About CDT Equity Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Net income
-$39.2M
Total assets
$5.7M
Market cap
$3.6M

Source: SEC EDGAR · updated Jun 8, 2026

NASDAQ: CDT

15-minute delayed · data by Polygon.io

Market cap
$3.6M
Open
Day range
Prev close
Volume
IPO date
Sep 25, 2023

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review CDT Equity Inc..

Write a review
Explore

Similar companies

Browse all →